|
Scientific Programme
|
Track Information |
|
|
|
|
Fundacao Oswaldo Cruz, Brazil
University of Liverpool, UK
Indian Institute of Toxicology Research, India
Institute of Chemical Technology, India
University of California, USA
|
Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 ms,
MRC Centre for Drug Safety Science,
Dept. Pharmacology |
Track 5-1: Biomarkers in Toxicology |
Session Chair: |
Dr. Rita Mattos, Senior Researcher,
National School of Public Health,
Fundacao Oswaldo Cruz,
Ministry of Health, Brazil.
|
Session Co-Chair: |
Dr. Dominic Willia & Therapeutics,
Sherrington Building,
The University of Liverpool,
Liverpool, UK. |
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Title: TBD
Dr. Kar Chowdhuri, Scientist F and Deputy Director,
Embryotoxicology Lab,
Indian Institute of Toxicology Research,
P.O. Box No. 80,
Mahatma Gandhi Marg,
Lucknow 226 001,
Uttar Pradesh,
India.
|
8:35-9:00 |
Title: Advances and Strategies in Using Biomarkers in Children Lead Exposure
Dr. Rita Mattos, Senior Researcher,
National School of Public Health,
Fundacao Oswaldo Cruz,
Ministry of Health, Brazil.
|
9:25-9:50 |
Title: TBD
Dr. Maibach Howard, Dermatology,
University of California, Sanfransisco, CA, USA.
|
9:50-10:15 |
Speech Opportunity Available |
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title: Biomarkers of Drug-Induced Liver Injury
Dr. Dominic Williams,
MRC Centre for Drug Safety Science,
Dept. Pharmacology & Therapeutics,
Sherrington Building,
The University of Liverpool,
Liverpool, UK.
|
10:50-11:15 |
Speech Opportunity Available |
11:15-11:40 |
Title: Biomarkers in Neurotoxicity
Dr. Sadhana Sathaye,
Reader in Pharmacy,
Dept. of Pharm. Sci. and Tech.,
Institute of Chemical Technology,
Matunga, Mumbai, India.
|
11:40-12:00 |
Panel Discussion |
|
|
Bio-Acoustic-MEMS in Medicine Laboratory, USA
Synthon BV,
The Netherlands
Research Center for Pharmaceutical Nanotechnology, Iran
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 5-2: Toxicogenomics & Metabolomics |
Session Chair: |
Call for Host |
Session Co-Chair: |
Dr. Utkan Demirci,
Bio-Acoustic-MEMS in Medicine (BAMM)Laboratory,
Center for Bioengineering,
Department of Medicine,
Brigham and Women’s Hospital,
Harvard Medical School, Boston, MA, USA. |
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Title: TBD
Dr. Utkan Demirci,
Bio-Acoustic-MEMS in Medicine (BAMM)Laboratory,
Center for Bioengineering,
Department of Medicine,
Brigham and Women’s Hospital,
Harvard Medical School,
Boston, MA, USA.
|
13:30-13:55 |
Speech Opportunity Available |
13:55-14:20 |
Title: TBD
Dr. Sandra van Os, Project Leader Clinical R&D,
Synthon BV,
Microweg 22,
6503 GN Nijmegen,
The Netherlands.
|
14:20-14:45 |
Speech Opportunity Available |
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Nonviral Cationic Gene Delivery Nanosystems: Geno compatibility and Toxicogenomics Dilemma
Dr. Y. Omidi,
Associate Professor, Faculty of Pharmacy,
Director, Research Center for Pharmaceutical Nanotechnology,
Dean, School of Advanced Biomedical Sciences,
Tabriz University of Medical Sciences,
Tabriz, Iran.
|
16:45-17:10 |
Speech Opportunity Available |
17:10-17:35 |
Speech Opportunity Available |
17:35-18:00 |
Panel Discussion |
|
|
Al-Qassim University,
Saudi Arabia
University of Madras, India
SRM University, India
University of Peradeniya,
Sri Lanka
National Institute for Research in Reproductive Health, India
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 5-3: Environmental Toxicology |
Session Chair: |
Call for Host |
Session Co-Chair: |
Dr. Sivakumar Gowder, Associate Professor,
Dept. Pharmacology & Biochemistry, Al-Qassim University,
College of Pharmacy, Buraidah, Saudi Arabia. |
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Speech Opportunity Available |
9:00-9:25 |
Title: Effect of Antioxidants on PCB Induced Changes in Male Reproduction
Dr. Arunakaran J, Department of Endocrinology,
Dr. ALM PGIBMS,
University of Madras,
Chennai,
India.
|
9:25-9:50 |
Title: Composite Ion Exchange Materials and their Applications to Remove Toxic Metal Ions
Dr. MU. Naushad, SRM University,
NCR Campus,
Modinagar, India.
|
9:50-10:15 |
Title: Kidney, the Major Organ in the Body to Evaluate Toxic and Transport Properties of Environmental Chemicals
Dr. Sivakumar Gowder, Associate Professor,
Dept. Pharmacology & Biochemistry, Al-Qassim University,
College of Pharmacy, Buraidah, Saudi Arabia.
|
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title: Impact of Melatonin on PCB Induced Neurotoxicity
Dr. P. Venkataraman.
Assistant Professor,
Department of Medical Research,
SRM Medical College Hospital and Research Centre,
SRM University, Kattankulathur - 603 203.
India.
|
10:50-11:15 |
Title: Attitude and Knowledge of Nonsmokers about Secondhand Smoke and their Opinion towards Cessation of Smoking in Malaysia – Findings from International Tobacco Control (ITC) Survey Malaysia
Dr. Mohamed Shukry Zawahir,
South Asian Clinical Toxicology Research Collaboration,
Faculty of Medicine, University of Peradeniya, Peradeniya,
Sri Lanka.
|
11:15-11:40 |
Title: Exposure to Bisphenol A, an Environmental Estrogen on Reproductive Health
Dr. Geeta Vanage,
National Center for Preclinical Reproductive and Genetic Toxicology,
National Institute for Research in Reproductive Health (ICMR),
Street, Parel, Mumbai 400 012, Maharashtra, India.
|
11:40-12:00 |
Panel Discussion |
|
|
Indian Institute of Chemical Technology, India
Centre for Cellular and Molecular Biology, India
Yokohama City University, Japan
Children's Hospital Medical Center, USA
Philip Morris International
Radboud University Nijmegen Medical Center, The Netherlands |
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 5-4: Molecular Epidemiology |
Session Chair: |
Dr. U. S. N Murthy, Director Grade Scientist/Scientist G,
Head Biology Division,
Indian Institute of Chemical Technology (CSIR),
Ministry of Science and Technology Govt India,
Tarnaka, Hyderabad, India. |
Session Co-Chair: |
Dr. M.V Jagannadham,
Scientist, Centre for Cellular and Molecular Biology,
Tarnaka, Hyderabad -500 007, India. |
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Speech Opportunity Available |
13:30-13:55 |
Title: TBD
Dr. Yoshihiro Ishikawa, Dean, Graduate School of Medicine,
Professor and President,
Cardiovascular Research Institute,
Yokohama City University,
Graduate School of Medicine,
Jap
|
13:55-14:20 |
Title: TBD
Prof. Michael V. Miles, Clinical Pediatrics and Neurology,
Div. of Pathology & Laboratory Medicine,
Children's Hospital Medical Center,
3333 Burnet Ave.,
Cincinnati,
OH 45229, USA.
|
14:20-14:45 |
Titel: Cigarette Smoke Inhalation Study for Lung Tumorigenicity in A/J Mice
Dr. Rosemarie B. Lichtner,
Philip Morris Research Laboratories GmbH, Germany.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: TBD
Prof. Thamar Stollman, Department of Surgery,
Radboud University Nijmegen Medical Center,
Nijmegen,
The Netherlands.
|
16:45-17:10 |
Title: Artificial Intelligence : A Magic Bullet for Epidemiological Studies of Vector Borne Diseases
Dr. U.S.N Murthy, Director Grade Scientist/Scientist G,
Head Biology Division,
Indian Institute of Chemical Technology (CSIR),
Ministry of Science and Technology Govt India,
Tarnaka, Hyderabad, India.
|
17:10-17:35 |
Title: The Proteome of the Outer Membrane Vesicles of an Antarctic Bacterium Pseudomonas Syringae
Dr. M.V Jagannadham,
Scientist, Centre for Cellular and Molecular Biology,
Tarnaka, Hyderabad, India.
|
17:35-18:00 |
Panel Discussion |
|
|
|
Track 6: PK/PD and Drug Discovery |
|
Shandong University School Of Medicine, China
Aizant Drug Research Solutions, India
Piramal Life Sciences, India
Meerut Institute of Engineering and Technology, India
Florida A & M University, USA
Indian Institute of Technology, India
|
Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 6-1: Anticancer, Antiviral Drug Development |
Session Chair: |
Dr. Harish Joshi,
Laboratory of Drug Discovery,
Design and Research,
Department of Cell Biology,
Suite 455 Whitehead Bld., WBRB,
615 Michael Street,
Atlanta,
GA-30322, USA. |
Session Co-Chair: |
Dr. Guo Rui Chen, Institute of Clinical Pharmacology,
Qilu Hospital of Shandong University, Jinan, Shandong, China.
|
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Title: Challenges in siRNA/shRNA Delivery and Development of RNAi Therapeutics for Cancer
Dr. Tathagata Dutta,
Deputy Director,
Formulation Developm Tathagata Duttaent and Drug Discovery Research,
Aizant Drug Research Solutions,
Hyderabad, India.
|
9:00-9:25 |
Title: Pharmacokinetics,
Metabolism and Tissue Distribution of Norcantharidin in Human Body,
Studied by HPLC-MS/MS and Isotope-labeled Methods
Dr. Guo Rui Chen, Institute of Clinical Pharmacology,
Qilu Hospital of Shandong University, Jinan, Shandong, China.
|
9:25-9:50 |
Title: Recent Advances in Anticancer Drug Discovery: Multiple Target Approach to Tackle Tough Tumors
Dr. Sanjay Kumar, Group Leader,
Department of Medicinal Chemistry,
Piramal Life Sciences,
Nirlon Complex, Off Western Express Highway,
Goregaon (E),
Mumbai 400 063, India.
|
9:50-10:15 |
Title: Quantitative Structure-Activity Relationship Studies on Anti-Hepatitis Viral Agents
Dr. S.P.Gupta, Departemt of Pharmaceutical Technology,
Meerut Institute of Engineering and Technology, Meerut, India.
|
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title: Targetted therapy for Treatment of Lung Cancer
Dr. Mandip Singh Sachdeva, Professor and section Leader, Pharmaceutics,
Florida A & M University,
College of Pharmacy,
Editor in Chief, CRC Critical Reviews in Therapeutic Drug Carrier Systems,
Tallahassee, Florida, USA.
|
10:50-11:15 |
Title: Hopeful Trip from Herbs to Humans
Dr. Harish Joshi,
Laboratory of Drug Discovery,
Design and Research,
Department of Cell Biology,
Suite 455 Whitehead Bld., WBRB,
615 Michael Street,
Atlanta,
GA-30322, USA.
|
11:15-11:40 |
Title: Nano-drug Deliverysystem Particularly for Anti-cancer Drug
Prof P.Pramanik,
nano-materials laboratory,
Chemistry Department,
Indian Institute of Technology,
Kharagpur,
721302 , India.
|
11:40-12:00 |
Panel Discussion |
|
|
University at Buffalo, USA
Ludwig-Maximilians University, Germany
University of Alberta, Canada
Indian Institute of Chemical Technology, India
Guru Jambheshwar University of Science and Technology, India |
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 6-2: Molecular Drug Targets and Fragment based Drug Design |
Session Chair: |
Dr. Wojciech Krzyzanski, Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA. |
Session Co-Chair: |
Dr. Nazaré Soeiro |
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Title: Assessment of Exposure to Carcinogens: Correlation of Surrogate Biomarkers with Adducts in Target Tissues
Dr. Franky Richter, Walther Straub Institute,
Department of Toxicology, Ludwig-Maximilians University, Germany.
|
13:30-13:55 |
Speech Opportunity Available |
13:55-14:20 |
Title: Minimal Effective Concentration and Efficacy of Epoetins
Dr. Wojciech Krzyzanski, Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA.
|
14:20-14:45 |
Title: TBD
Dr. Fakhreddin Jamali,
Faculty of Pharmacy & Pharmaceutical Sciences,
University of Alberta,
Edmonton, Alberta, Canada.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: TBD
Dr. Nazaré Soeiro
|
16:45-17:10 |
Title: Biophotonics: Application towards Modern Drug Discovery
Dr. Srinivas kantevari, Sr. Scientist,
Organic Chemistry Division-II,
Indian Institute of Chemical Technology,
Hyderabad, India.
|
17:10-17:35 |
Title: Molecular Drug Targets for Development of Antidepressant Drugs
Dr. Dinesh Dhingra,
Assistant Professor,
Pharmacology Division,
Department of Pharmaceutical Sciences,
Guru Jambheshwar University of Science and Technology,
Hisar-125001-Haryana, India.
|
17:35-18:00 |
Panel Discussion |
|
|
Kuwait University, Kuwait
Panjab University, India
Monash Institute of Pharmaceutical Sciences, Australia
AstraZeneca R&D Mölndal, Sweden
University of British Columbia, Canada
Rashtrasant Tukadoji Maharaj Nagpur University, India
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 6-3: Improving ADME/DMPK Profile |
Session Chair: |
Dr. Aly Nada,
Assoc.Professor & Chairman,
Department of Pharmaceutics,
Faculty of Pharmacy,
Kuwait University,
POB 24923 Safat, 13110 Kuwait. |
Session Co-Chair: |
Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University,
Chandigarh, India. |
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Title: TBD
Dr. Jian Li,
Facility for Anti-infective Drug Development and Innovation,
Drug Delivery, Disposition and Dynamics,
Monash Institute of Pharmaceutical Sciences,
Monash University, Australia.
|
9:00-9:25 |
Title: TBD
Dr. Hong Wan,
Lead Generation DMPK and Physical Chemistry,
AstraZeneca R&D Mölndal, Sweden.
|
9:25-9:50 |
Title: Stability and Rat Skin Permeation of Vitamin E and Vitamin E Acetate in Cosmetic Preparations
Dr. Aly Nada,
Assoc.Professor & Chairman,
Department of Pharmaceutics,
Faculty of Pharmacy,
Kuwait University,
POB 24923 Safat, 13110 Kuwait.
|
9:50-10:15 |
Title: TBD
Dr. William Jia,
Department of Surgery,
Faculty of Medicine,
University of British Columbia,
Brain Research Centre, Canada.
|
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title: Enhancing Oral Bioavailability of Drugs using Self-Emulsifying Drug Delivery Systems
Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University,
Chandigarh, India.
|
10:50-11:15 |
Title: Pharmacokinetic Significance of Diabetes-induced Changes in CYP3A Activity
Prof. S. N. Umathe,
Head of Pharmacology Division,
Department of Pharmaceutical Sciences,
Rashtrasant Tukadoji Maharaj Nagpur University,
Mahatma Jyotiba Fuley Shaikshanik Parisar,
Amravati Road , Nagpur,
India.
|
11:15-11:40 |
Speech Opportunity Available |
11:40-12:00 |
Panel Discussion |
|
|
Mayo Clinic School of Medicine, USA
Institut Supérieur de Biotechnologies de Sfax, Tunisie
Vaagdevi college of Pharmacy, India
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 6-4: PK/PD and Bioanalysis Outsourcing Alliance |
Session Chair: |
Prof. Debabrata Mukhopadhyay,
Department of Biochemistry and Molecular Biology,
Mayo Clinic School of Medicine,
Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905, USA. |
Session Co-Chair: |
Dr. Anupama Ramkumar, Director,
Arkus CTSS,
Ahmedabad, India. |
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Speech Opportunity Available |
13:30-13:55 |
Title: More than a Co-receptor: New Perspectives of Neuropilin-1 Function in Endothelium and Tumor Cells
Prof. Debabrata Mukhopadhyay,
Department of Biochemistry and Molecular Biology,
Mayo Clinic School of Medicine,
Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905, USA.
|
13:55-14:20 |
Title: TBD
Dr.c
Institut Supérieur de Biotechnologies de Sfax,
Route de Soukra km 4,
Sfax 3038, Tunisie.
|
14:20-14:45 |
Title: TBD
Dr. S.cc
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Bioequivalence Studies for Generics in Patients - Trials or Tribulations?
Dr. Anupama Ramkumar,
Director,
Arkus CTSS,
Ahmedabad, India.
|
16:45-17:10 |
Title: Local Antibiotic Delivery Systems for the Treatment of Osteomyelitis, the Use of Fibrin Clot as a Carrier- an In Vitro and In Vivo Pharmacokinetic Study
Dr. Stefanos Tsourvakas,
Orthopaedic Department,
General Hospital of Trikala, Greece.
|
17:10-17:35 |
Title: Pharmacokinetic Study of Hair Dye Poisoning: A Study of 50 cases
Dr. M. Nagulu,
Department of Clinical Pharmacy Services,
M.G.M Hospital, Vaagdevi college of Pharmacy, Warangal, India.
|
17:35-18:00 |
Panel Discussion |
|
|
Central Drug Research Institute, India
Sun Pharma, India
Jahaharlal Nehru Technological University, India
Satara College of Pharmacy, India
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 6-5: Road Map to Drug Discovery and Develoment |
Session Chair: |
Dr. Girish kumar jain,
Head, Division of Pharmacokinetics & Metabolism,
Central Drug Research Institute,
Lucknow-226001, India. |
Session Co-Chair: |
Dr. Sanjay Mandhane,
Pharmacology Division,
Sun Pharma Advanced Research Company Limited,
Atladara, Tandalja Road, Vadodara, Gujarat 390 020, India. |
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Title: Is Natural Product Domain a Good Hunting Hub in the Navigation of Drug Like and Drug Molecules?
Dr. A. Jayashree, Scientist,
Jahaharlal Nehru Technological University, Hyderabad, India.
|
13:30-13:55 |
Speech Opportunity Available |
13:55-14:20 |
Title: Materials and Methods for Innovation-Are We Ready for Drug Discovery?
Dr. Sanjay Mandhane,
Pharmacology Division,
Sun Pharma Advanced Research Company Limited,
Atladara, Tandalja Road, Vadodara, Gujarat 390 020, India.
|
14:20-14:45 |
Speech Opportunity Available |
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Therapeutic Alternatives from Venoms and Toxins : Drug Challenges of the Future
Prof. Shivaji P.Gawade,
Professor in Pharmacology and Principal,
Satara College of Pharmacy,
Plot 1539,
New Additional MIDC,
Behind Spicer India Ltd,
Degaon, Satara, M.S., India.
|
16:45-17:10 |
Title: Human Membrane Guanylate Cyclases: Understanding the Structural Basis of Receptor-Ligand Interactions and Approaches to Drug Design
Prof. Paul Roesch, Research Center for Bio-Macromolecules,
U. of Bayreuth 95440 Bayreuth, Germany.
|
17:10-17:35 |
Speech Opportunity Available |
17:35-18:00 |
Panel Discussion |
|
|
|
|
All India Institute of Medical Sciences, India
Govt. College of Pharmacy, India
|
Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 7-1: Influence of Disease on Bioavailability |
Session Chair: |
Call for Host |
Session Co-Chair: |
Dr. Thirumurthy velpandian,
Associate Professor & In-Charge,
Department of Ocular Pharmacology & Pharmacy,
Dr.Rajendra Prasad Centre for Ophthalmic Sciences,
All India Institute of Medical Sciences,
New Delhi, India. |
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Title: Liver Diseses Affecting Bioavailability
Dr. Dibya Sundar Panda, Institute of Pharmacy and Technology, Salipur-754202, Cuttack, India.
|
9:00-9:25 |
Speech Opportunity Available |
9:25-9:50 |
Title: Pros and Cons of Ocular bio-availability of Drugs
Dr. Thirumurthy velpandian,
Associate Professor & In-Charge,
Department of Ocular Pharmacology & Pharmacy,
Dr.Rajendra Prasad Centre for Ophthalmic Sciences,
All India Institute of Medical Sciences,
New Delhi, India.
|
9:50-10:15 |
Speech Opportunity Available |
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title: TBD
Dr. Motte Laurence,
Université Paris,
Nanomaterials group,
CSPBAT Laboratory, France.
|
10:50-11:15 |
Title: Are Bioavailability Studies Warranted in Specific Disease States?
Dr. S.B. Bhise, Principal,
Govt. College of Pharmacy,
Karad, India.
|
11:15-11:40 |
Speech Opportunity Available |
11:40-12:00 |
Panel Discussion |
|
|
Andhra University, India
Novartis, USA
University Children's Hospital Basel, Switzerland
University of Kentucky School of Medicine, USA
Huashan hospital of Fudan University, China
Jagiellonian University
Royal College of Surgeons in Ireland, Ireland
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 7-2: Factors Influencing Bioavailability and Bioequivalence |
Session Chair: |
Prof. T. Satyanarayana,
Principal,
College of Pharmaceutical Sciences,
Andhra University,
Visakhapatnam, India. |
Session Co-Chair: |
Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS),
USEH, 436/3253,
One Health Plaza,
East Hanover, NJ 07936-1080, USA.
|
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Title: Immunomodulation by Biologic Intravenous Immunoglobulins IVIG: Immune Thrombocytopenia ITP as a Model for the last 30 Years
Dr. Paul Imbach, University Children's Hospital Basel UKBB, Basel, Switzerland
|
13:30-13:55 |
Title: The Bioavailability of Heparin-binding Molecules on Vascular Walls is Regulated by Heparan Sulfate and Flow Rate
Dr. Michael Fannon,
University of Kentucky School of Medicine,
Lexingto
|
13:55-14:20 |
Title: TBD
Dr. Peinan Sun,
The Department of Clinical Pharmacology,
Huashan hospital of Fudan University,
Shanghai, China.
|
14:20-14:45 |
Title: Factors Influencing Bioavailability and Bioequivalence
Prof. Vijaya Ratna, AU College of Pharmaceutical Sciences,
Andhra University, Visakhapatnam, India.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Roles of Oral Drug Absorption, Bioavailability and Exposure Prediction in Drug Development
Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS),
USEH, 436/3253,
One Health Plaza,
East Hanover, NJ 07936-1080,
USA.
|
16:45-17:10 |
Title: Combining Population-based Mechanistic Modeling of Oral Absorption and Parameter Estimation Algorithms to Obtain Reliable Predictions of Bioavailability
Prof. Sebastian Polak, Jagiellonian Univ,
Krakow,
Poland and Simcyp, Poland.
|
17:10-17:35 |
Title: Aspirin Resistance: The Role of Poor Bioavailability of Enteric Coated Aspirin
Dr. Dermot Cox,
Molecular and Cellular Therapeutics,
Royal College of Surgeons in Ireland,
123 St. Stephens Green,
Dublin 2,
Ireland.
|
17:35-18:00 |
Panel Discussion |
|
|
KLE University, India
University of Texas at Austin, USA
Saudi Food and Drug Authority, Saudi Arabia
University of Ljubljana, Slovenia
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 7-3: The Role of Intestinal Metabolism on Bioavailability |
Session Chair: |
Prof. Basavaraj K. Nanjwade,
Department of Pharmaceutics,
JN Medical college,
KLE University,
Belgaum- 590010,
Karnataka, India.
|
Session Co-Chair: |
Call for Co-Host |
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Title: Challenges in Establishing Bioequivalence of Complex Modified Release Dosage Forms
Dr. Salomon Stavchansky, Division of Pharmaceutics,
College of Pharmacy,
University of Texas at Austin, Austin, Texas, USA.
|
9:00-9:25 |
Speech Opportunity Available |
9:25-9:50 |
Title: TBD
Dr. Abdullah Al-Mohizea,
Director of Product Evaluation and Standard Setting Department,
Drug Sector,
Saudi Food and Drug Authority,
Riyadh, Saudi Arabia.
|
9:50-10:15 |
Title: The Importance of Intestinal Wall Metabolism – the Case of Raloxifene
Dr. Trontelj Jurij, Dept. Biopharmacy and Pharmacokinetics,
Faculty of Pharmacy,
University of Ljubljana Askerceva 7, Ljubljana, Slovenia.
|
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title: Enhancing Drug Bioavailability by Overcoming Intestinal Metabolism
Prof. Basavaraj K. Nanjwade,
Department of Pharmaceutics,
JN Medical college,
KLE University,
Belgaum- 590010,
Karnataka, India.
|
10:50-11:15 |
Title: Enhancement of Bioavailability of Aceclofenac Using Solid Dispersion Technique
Dr. Sharma V. K, D.J. College of Pharmacy, Modinagar, 201204, UP, India.
|
11:15-11:40 |
Speech Opportunity Available |
11:40-12:00 |
Panel Discussion |
|
|
Cetero Research, USA
Panacea Biotec Ltd., India
Y.B. Chavan College of Pharmacy, India
Panjab University, India
Dibrugarh University, India
M. L. Sukhadia University, India
Dr H S Gour University,
India
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 7-4: In Vitro Methods to Determine Bioavailability & In Vitro-In Vivo Correlations |
Session Chair: |
Dr. Sam Raney,
Associate Director, Pre-Clinical Dermatology,
Cetero Research, Adjunct Professor of Pharmaceutical Sciences at North Dakota State University, USA.
|
Session Co-Chair: |
Dr. Shivanand Puthli, Drug Delivery Division,
Panacea Biotec Ltd., Navi-Mumbai, Maharashtra, India. |
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Title: Assessing BA/BE of Topical Formulations In Vitro:
In Vitro – In Vivo Correlation Provides a Practical Surrogate to Clinical BE Studies
Dr. Sam Raney,
Associate Director, Pre-Clinical Dermatology,
Cetero Research, Adjunct Professor of Pharmaceutical Sciences at North Dakota State University, USA.
|
13:30-13:55 |
Title: Understanding the Significance of In-vitro/ In-vivo Correlation in Pharmacokinetic Predictions
Dr. Shivanand Puthli, Drug Delivery Division,
Panacea Biotec Ltd., Navi-Mumbai, Maharashtra, India.
|
13:55-14:20 |
Title: In Vitro Methods to Determine Bioavailability & IVIVC of Oral Dosage Forms and Drug Delivery Systems
Dr. Vijay D. Wagh,
Associate Professor In Pharmaceutics,
Y.B. Chavan College of Pharmacy, Aurangabad.
and
Editor In Chief,
Indian Journal of Pharmaceutics,
Serial Publications, Daria Ganj,
New Delhi, India.
|
14:20-14:45 |
Title: Endeavoring Biowaivers Using IVIVC: Shifting Paradigms
Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University,
Chandigarh, India.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Transdermal Bioavailability of Trazodone Hydrochloride: Invitro-Invivo Correlation
Dr. Malay K. Das, Division of Pharmaceutics,
Department of Pharmaceutical Sciences,
Dibrugarh University,
Dibrugarh 786004, India.
|
16:45-17:10 |
Title: Effect of Test Parameters on In-vitro Method to Determine Bioavailability of Dosage Forms
Dr. Abhishek kumar Jain,
Research Scholar and Lecturer,
Department of Pharmaceutical Science,
M. L. Sukhadia University,
Udaipur, Rajasthan, India.
|
17:10-17:35 |
Title: TBD
Dr. Avijeet Jain,
Research Scholar,
Natural Product Research Laboratory,
Dept of Pharmaceutical Sciences,
Dr H S Gour University,
Sagar, MP, India.
|
17:35-18:00 |
Panel Discussion |
|
|
|
|
|
University of Notre Dame, USA
Faculty of Medicine Siriraj Mahidol University, Thailand
Nova Southeastern University, USA
The Australian National University Medical School, University of Canberra, Australia
University of Hyderabad, India
Panjab University, Chandigarh, India
Institute of Biotechnology and Antibiotics, Warsaw, Poland
Texas Tech School of Pharmacy, USA
University of Petra, Jordan
Jadavpur University, India
University of British Columbia, Canada
Canadian Society for Pharmaceutical Sciences, Canada
National University of Singapore, Singapore
King Saud University, Saudi Arabia
Widener University, USA
Stanford University School of Medicine, USA
University at Buffalo, State University of New York, USA
School of Biological Sciences, University of Edinburgh, UK
Chungnam National University, Korea
Harvard Medical School, USA
Polish Academy of Sciences, Poland
University of Trieste, Italy
College of Pharmaceutical Sciences, MAHE, India
Medical School, University of Athens, Greece
Universiade Federal da Bahia, Instituto de Cięncias da Saude, Brazil
University of Region of Cariri - URCA, Brazil
Tabriz University of Medical Sciences, Iran
Johns Hopkins University, USA
Creighton University Medical Center and University of Nebraska Medical Center, USA
University of Pisa, Italy
The University of Liverpool, UK
The Islamia University of Bahawalpur, Pakistan
University of California, Sanfransisco, USA
Al-Qassim University, College of Pharmacy Buraidah, Saudi Arabia
University of Madras, India
SRM University NCR Campus, India
University of Peradeniya, Sri Lanka
Yokohama City University, Graduate School of Medicine, Japan
Radboud University Nijmegen Medical Center, The Netherlands
Qilu Hospital of Shandong University, China
Meerut Institute of Engineering and Technology, India
Florida A & M University, College of Pharmacy, USA
Jawaharlal Nehru Technological University, India
Ludwig-Maximilians University, Germany
V.L. College of Pharmacy, India
University of Alberta, Canada
Panjab University, India
Monash Institute of Pharmaceutical Sciences, Monash University, Australia
University of British Columbia, Brain Research Centre, Canada
Univ Inst Pharm Sci (UGC Center of Adv Studies), Panjab University, India
Institut Supérieur de Biotechnologies de Sfax, Tunisie
All India Institute of Medical Sciences, India
Rhodes University, South Africa
Université Paris, France
Faculty of Pharmacy, University of Ljubljana Askerceva 7, Slovenia
Chungnam National University, Korea
Dr H S Gour University, India
National School of Public Health, Ministry of Health, Brazil
University of Toronto, Canada
Oncology Institute of Vojvodina , Serbia
Indian Institute of Chemical Technology, India
Indian Institute of Toxicology Research, India
Einstein Heart and Vascular Institute, Albert Einstein Medical Center, USA
University of Texas at Austin, USA
National Institute for Research in Reproductive Health (ICMR), India
National Cancer Institute, USA
|
|
US Pharmacopeia, USA
Food and Drug Administration, USA
University Hospital Zurich, Switzerland
B. V. Patel Perd Centre, India
Guy's Hospital, UK
HĂ´pital Saint-Antoine, Paris
A. Manzoni Hospital, Italy
Kazusa DNA Research Institute, Japan
Pharmaceutics Int., Inc., USA
Agilent Technologies, USA
Central Drug Research Institute, India
EMF Consulting, France
Hopital Cochin, Paris
Boys Town National Research Hospital, Omaha, USA
Aurobindo Pharma Ltd., India
Abbott labs, USA
Synthon BV, The Netherlands
Children's Hospital Medical Center, USA
Piramal Life Sciences, India
AstraZeneca R&D Mölndal, Sweden
Sun Pharma Advanced Research Company Limited, India
Ranbaxy Research Laboratories, India
University Children's Hospital Basel UKBB, Switzerland
Huashan hospital of Fudan University, China
Novartis Institutes for BioMedical Research, USA
Defence Research and Development Canada Suffield, Canada
Saudi Food and Drug Authority, Saudi Arabia
Cetero Research, USA
Panacea Biotec Ltd., India
Lupin Ltd., India
|
|
|